Non-compliance with antituberculous drugs

Area of Science:

• Clinical Medicine
• Pharmacology
• Public Health

Background:

• Adherence to antituberculous drug regimens is crucial for successful tuberculosis treatment and preventing drug resistance.
• Non-compliance can lead to treatment failure, prolonged infectiousness, and the emergence of multidrug-resistant tuberculosis.
• Monitoring patient adherence is a significant challenge in tuberculosis management.

Observation:

• A case of complete, unintentional non-compliance with a full course of antituberculous medications was identified.
• The study assessed the utility of routine urine testing for rifampicin as a method to detect non-adherence.
• The butanol extraction test was specifically evaluated for its practicality in a clinical setting.

Findings:

• The butanol extraction test for rifampicin in urine proved to be a straightforward and quick method.
• This test effectively identified patients who were not adhering to their prescribed antituberculous drug regimen.
• The test serves as a valuable tool for detecting defaulting patients in chest clinic settings.

Implications:

• Routine urine rifampicin testing can enhance tuberculosis treatment adherence monitoring.
• Early identification of non-compliant patients allows for timely intervention and support.
• Implementing this simple test may improve treatment outcomes and reduce the spread of tuberculosis.